{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:28:42Z","timestamp":1716380922833},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00120-018-0575-9","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T12:47:51Z","timestamp":1517575671000},"page":"285-294","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ablative Therapien kleiner Nierentumoren"],"prefix":"10.1007","volume":"57","author":[{"given":"M. C.","family":"Kriegmair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Rathmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"key":"575_CR1","unstructured":"S3-Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms. AWMF-Registernummer: 043\/017-OL 2017."},{"key":"575_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1309\/AJCPLBK9L9KDYQZP","volume":"137","author":"M Pichler","year":"2012","unstructured":"Pichler M, Hutterer GC, Chromecki TF et\u00a0al (2012) Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol 137:283\u2013289","journal-title":"Am J Clin Pathol"},{"key":"575_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.juro.2009.02.128","volume":"182","author":"RH Thompson","year":"2009","unstructured":"Thompson RH, Hill JR, Babayev Y et\u00a0al (2009) Metastatic renal cell carcinoma risk according to tumor size. J\u00a0Urol 182:41\u201345","journal-title":"J Urol"},{"key":"575_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11934-016-0611-5","volume":"17","author":"N Kavoussi","year":"2016","unstructured":"Kavoussi N, Canvasser N, Caddedu J (2016) Ablative therapies for the treatment of small renal masses: a\u00a0review of different modalities and outcomes. Curr Urol Rep 17:59","journal-title":"Curr Urol Rep"},{"key":"575_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1148\/radiol.11091207","volume":"261","author":"AM Venkatesan","year":"2011","unstructured":"Venkatesan AM, Wood BJ, Gervais DA (2011) Percutaneous ablation in the kidney. Radiology 261:375\u2013391","journal-title":"Radiology"},{"key":"575_CR6","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.juro.2016.04.063","volume":"196","author":"D Moskowitz","year":"2016","unstructured":"Moskowitz D, Chang J, Ziogas A, Anton-Culver H, Clayman RV (2016) Treatment for T1a renal cancer substratified by size: \u201cless is more\u201d. J\u00a0Urol 196:1000\u20131007","journal-title":"J Urol"},{"key":"575_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.tvir.2013.08.010","volume":"16","author":"DS Lu","year":"2013","unstructured":"Lu DS, Kee ST, Lee EW (2013) Irreversible electroporation: ready for prime time? Tech Vasc Interv Radiol 16:277\u2013286","journal-title":"Tech Vasc Interv Radiol"},{"key":"575_CR8","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1148\/rg.345140054","volume":"34","author":"JL Hinshaw","year":"2014","unstructured":"Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT Jr., Brace CL (2014) Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation \u2013 what should you use and why? Radiographics 34:1344\u20131362","journal-title":"Radiographics"},{"key":"575_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1553350613505713","volume":"21","author":"I Al-Alem","year":"2014","unstructured":"Al-Alem I, Pillai K, Akhter J, Chua TC, Morris DL (2014) Heat sink phenomenon of bipolar and monopolar radiofrequency ablation observed using polypropylene tubes for vessel simulation. Surg Innov 21:269\u2013276","journal-title":"Surg Innov"},{"key":"575_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/089277904322836749","volume":"18","author":"J Rehman","year":"2004","unstructured":"Rehman J, Landman J, Lee D et al (2004) Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J\u00a0Endourol 18:83\u2013104","journal-title":"J Endourol"},{"key":"575_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/01.ju.0000165655.91152.c5","volume":"174","author":"IM Varkarakis","year":"2005","unstructured":"Varkarakis IM, Allaf ME, Inagaki T et al (2005) Percutaneous radio frequency ablation of renal masses: results at a\u00a02-year mean followup. J\u00a0Urol 174:456\u2013460 (discussion 60)","journal-title":"J Urol"},{"key":"575_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/01.RVI.0000204853.75376.2C","volume":"17","author":"TW Clark","year":"2006","unstructured":"Clark TW, Malkowicz B, Stavropoulos SW et\u00a0al (2006) Radiofrequency ablation of small renal cell carcinomas using multitined expandable electrodes: preliminary experience. J\u00a0Vasc Interv Radiol 17:513\u2013519","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.urology.2010.12.077","volume":"77","author":"RJ Zagoria","year":"2011","unstructured":"Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR (2011) Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 77:1393\u20131397","journal-title":"Urology"},{"key":"575_CR14","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1089\/end.2009.0639","volume":"24","author":"N Ferakis","year":"2010","unstructured":"Ferakis N, Bouropoulos C, Granitsas T, Mylona S, Poulias I (2010) Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J\u00a0Endourol 24:1909\u20131913","journal-title":"J Endourol"},{"key":"575_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.eururo.2012.08.062","volume":"63","author":"SP Psutka","year":"2013","unstructured":"Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486\u2013492","journal-title":"Eur Urol"},{"key":"575_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.tvir.2013.08.006","volume":"16","author":"C Georgiades","year":"2013","unstructured":"Georgiades C, Rodriguez R (2013) Renal tumor ablation. Tech Vasc Interv Radiol 16:230\u2013238","journal-title":"Tech Vasc Interv Radiol"},{"key":"575_CR17","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1016\/j.jvir.2009.12.403","volume":"21","author":"JP Erinjeri","year":"2010","unstructured":"Erinjeri JP, Clark TW (2010) Cryoablation: mechanism of action and devices. J\u00a0Vasc Interv Radiol 21:S187\u2013S191","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jvir.2011.11.019","volume":"23","author":"M Inoue","year":"2012","unstructured":"Inoue M, Nakatsuka S, Yashiro H et\u00a0al (2012) Percutaneous cryoablation of lung tumors: feasibility and safety. J\u00a0Vasc Interv Radiol 23:295\u2013302 (quiz 5)","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.acra.2010.08.006","volume":"18","author":"A Pirasteh","year":"2011","unstructured":"Pirasteh A, Snyder L, Boncher N, Passalacqua M, Rosenblum D, Prologo JD (2011) Cryoablation vs. radiofrequency ablation for small renal masses. Acad Radiol 18:97\u2013100","journal-title":"Acad Radiol"},{"key":"575_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2214\/AJR.12.8618","volume":"200","author":"TD Atwell","year":"2013","unstructured":"Atwell TD, Schmit GD, Boorjian SA et\u00a0al (2013) Percutaneous ablation of renal masses measuring 3.0\u202fcm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol 200:461\u2013466","journal-title":"AJR Am J Roentgenol"},{"issue":"22","key":"575_CR21","first-page":"e1","volume":"33","author":"A Larcher","year":"2015","unstructured":"Larcher A, Fossati N, Mistretta F et al (2015) Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses. Urol Oncol 33(22):e1\u2013e9","journal-title":"Urol Oncol"},{"key":"575_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.urology.2014.03.055","volume":"84","author":"S Johnson","year":"2014","unstructured":"Johnson S, Pham KN, See W, Begun FP, Langenstroer P (2014) Laparoscopic cryoablation for clinical stage T1 renal masses: long-term oncologic outcomes at the Medical College of Wisconsin. Urology 84:613\u2013618","journal-title":"Urology"},{"key":"575_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/bju.13615","volume":"119","author":"TK Nielsen","year":"2017","unstructured":"Nielsen TK, Lagerveld BW, Keeley F et al (2017) Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a\u00a0European Registry for Renal Cryoablation (EuRECA) multi-institutional study. BJU Int 119:390\u2013395","journal-title":"BJU Int"},{"key":"575_CR24","first-page":"412","volume":"112","author":"M Regier","year":"2015","unstructured":"Regier M, Chun F (2015) Thermal ablation of renal tumors: indications, techniques and results. Dtsch Arztebl Int 112:412\u2013418","journal-title":"Dtsch Arztebl Int"},{"key":"575_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1820-0","author":"S Hebbadj","year":"2017","unstructured":"Hebbadj S, Cazzato RL, Garnon J et al (2017) Safety considerations and local tumor control following percutaneous image-guided cryoablation of T1b renal tumors. Cardiovasc Intervent Radiol. \n                    https:\/\/doi.org\/10.1007\/s00270-017-1820-0","journal-title":"Cardiovasc Intervent Radiol"},{"key":"575_CR26","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1007\/s00261-015-0500-2","volume":"40","author":"J Yu","year":"2015","unstructured":"Yu J, Zhang G, Liang P et\u00a0al (2015) Midterm results of percutaneous microwave ablation under ultrasound guidance versus retroperitoneal laparoscopic radial nephrectomy for small renal cell carcinoma. Abdom Imaging 40:3248\u20133256","journal-title":"Abdom Imaging"},{"key":"575_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11547-014-0426-8","volume":"119","author":"C Floridi","year":"2014","unstructured":"Floridi C, De Bernardi I, Fontana F et\u00a0al (2014) Microwave ablation of renal tumors: state of the art and development trends. Radiol Med 119:533\u2013540","journal-title":"Radiol Med"},{"issue":"Suppl 1","key":"575_CR28","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.5009\/gnl.2010.4.S1.S99","volume":"4","author":"EW Lee","year":"2010","unstructured":"Lee EW, Thai S, Kee ST (2010) Irreversible electroporation: a\u00a0novel image-guided cancer therapy. Gut Liver 4(Suppl 1):S99\u2013S104","journal-title":"Gut Liver"},{"key":"575_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2478\/v10019-012-0026-y","volume":"46","author":"OO Adeyanju","year":"2012","unstructured":"Adeyanju OO, Al-Angari HM, Sahakian AV (2012) The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma. Radiol Oncol 46:126\u2013135","journal-title":"Radiol Oncol"},{"key":"575_CR30","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1148\/radiol.13122590","volume":"269","author":"E Ben-David","year":"2013","unstructured":"Ben-David E, Ahmed M, Faroja M et al (2013) Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties. Radiology 269:738\u2013747","journal-title":"Radiology"},{"key":"575_CR31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jvir.2014.01.028","volume":"25","author":"HJ Scheffer","year":"2014","unstructured":"Scheffer HJ, Nielsen K, de Jong MC et\u00a0al (2014) Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a\u00a0systematic review of safety and efficacy. J\u00a0Vasc Interv Radiol 25:997\u20131011 (quiz)","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cct.2015.05.002","volume":"43","author":"JJ Wendler","year":"2015","unstructured":"Wendler JJ, Porsch M, Nitschke S et\u00a0al (2015) A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp Clin Trials 43:10\u201319","journal-title":"Contemp Clin Trials"},{"key":"575_CR33","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jvir.2016.03.044","volume":"27","author":"SJ Diehl","year":"2016","unstructured":"Diehl SJ, Rathmann N, Kostrzewa M et al (2016) Irreversible electroporation for surgical renal masses in solitary kidneys: short-term Interventional and functional outcome. J\u00a0Vasc Interv Radiol 27:1407\u20131413","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jvir.2010.12.014","volume":"22","author":"KR Thomson","year":"2011","unstructured":"Thomson KR, Cheung W, Ellis SJ et\u00a0al (2011) Investigation of the safety of irreversible electroporation in humans. J\u00a0Vasc Interv Radiol 22:611\u2013621","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR35","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jvir.2015.06.028","volume":"26","author":"CK Trimmer","year":"2015","unstructured":"Trimmer CK, Khosla A, Morgan M, Stephenson SL, Ozayar A, Cadeddu JA (2015) Minimally invasive Percutaneous treatment of small renal tumors with irreversible Electroporation: a single-center experience. J\u00a0Vasc Interv Radiol 26:1465\u20131471","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/MOU.0000000000000284","volume":"26","author":"N Singla","year":"2016","unstructured":"Singla N, Gahan J (2016) New technologies in tumor ablation. Curr Opin Urol 26:248\u2013253","journal-title":"Curr Opin Urol"},{"key":"575_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1349-3","author":"MF Rashid","year":"2017","unstructured":"Rashid MF, Hecht EM, Steinman JA, Kluger MD (2017) Irreversible electroporation of pancreatic adenocarcinoma: a\u00a0primer for the radiologist. Abdom Radiol (NY). \n                    https:\/\/doi.org\/10.1007\/s00261-017-1349-3","journal-title":"Abdom Radiol (NY)"},{"key":"575_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.eururo.2017.09.009","volume":"73","author":"B Bhindi","year":"2017","unstructured":"Bhindi B, Mason RJ, Haddad MM et\u00a0al (2017) Outcomes after Cryoablation versus partial nephrectomy for sporadic renal tumors in a\u00a0solitary kidney: a propensity score analysis. Eur Urol 73:254\u2013259","journal-title":"Eur Urol"},{"key":"575_CR39","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.juro.2011.11.099","volume":"187","author":"EE Young","year":"2012","unstructured":"Young EE, Castle SM, Gorbatiy V, Leveillee RJ (2012) Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses. J\u00a0Urol 187:1177\u20131182","journal-title":"J Urol"},{"key":"575_CR40","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00270-011-0281-0","volume":"35","author":"J Boone","year":"2012","unstructured":"Boone J, Bex A, Prevoo W (2012) Percutaneous radiofrequency ablation of a\u00a0small renal mass complicated by appendiceal perforation. Cardiovasc Intervent Radiol 35:695\u2013699","journal-title":"Cardiovasc Intervent Radiol"},{"key":"575_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2017.08.013","author":"JR Rivero","year":"2017","unstructured":"Rivero JR, De La Cerda J 3rd, Wang H et al (2017) Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. J\u00a0Vasc Interv Radiol. \n                    https:\/\/doi.org\/10.1016\/j.jvir.2017.08.013","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jvir.2011.09.008","volume":"23","author":"TD Atwell","year":"2012","unstructured":"Atwell TD, Carter RE, Schmit GD et\u00a0al (2012) Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. J\u00a0Vasc Interv Radiol 23:48\u201354","journal-title":"J Vasc Interv Radiol"},{"key":"575_CR43","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/bju.13841","volume":"119","author":"B Bhindi","year":"2017","unstructured":"Bhindi B, Thompson RH, Mason RJ et\u00a0al (2017) Comprehensive assessment of renal tumour complexity in a\u00a0large percutaneous cryoablation cohort. BJU Int 119:905\u2013912","journal-title":"BJU Int"},{"key":"575_CR44","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.juro.2016.04.081","volume":"196","author":"PM Pierorazio","year":"2016","unstructured":"Pierorazio PM, Johnson MH, Patel HD et al (2016) Management of renal masses and localized renal cancer: systematic review and meta-analysis. J\u00a0Urol 196:989\u2013999","journal-title":"J Urol"},{"key":"575_CR45","doi-asserted-by":"publisher","first-page":"e2255","DOI":"10.1097\/MD.0000000000002255","volume":"94","author":"X Yin","year":"2015","unstructured":"Yin X, Cui L, Li F, Qi S, Yin Z, Gao J (2015) Radiofrequency ablation versus partial nephrectomy in treating small renal tumors: a systematic review and meta-analysis. Medicine (Baltimore) 94:e2255","journal-title":"Medicine (Baltimore)"},{"key":"575_CR46","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2214\/AJR.13.11110","volume":"202","author":"GD Schmit","year":"2014","unstructured":"Schmit GD, Kurup AN, Weisbrod AJ et\u00a0al (2014) ABLATE: a\u00a0renal ablation planning algorithm. Ajr Am J Roentgenol 202:894\u2013903","journal-title":"Ajr Am J Roentgenol"},{"key":"575_CR47","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ejso.2016.08.023","volume":"43","author":"A Larcher","year":"2017","unstructured":"Larcher A, Sun M, Dell\u2019Oglio P et\u00a0al (2017) Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer. Eur J Surg Oncol 43:815\u2013822","journal-title":"Eur J Surg Oncol"},{"key":"575_CR48","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1681\/ASN.2015121335","volume":"27","author":"SL Hu","year":"2016","unstructured":"Hu SL, Chang A, Perazella MA et\u00a0al (2016) The Nephrologist\u2019s tumor: basic biology and management of renal cell carcinoma. J\u00a0Am Soc Nephrol 27:2227\u20132237","journal-title":"J Am Soc Nephrol"},{"key":"575_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.urology.2017.03.002","volume":"107","author":"J Dagenais","year":"2017","unstructured":"Dagenais J, Maurice MJ, Mouracade P et\u00a0al (2017) The synergistic influence of ischemic time and surgical precision on acute kidney injury after robotic partial nephrectomy. Urology 107:132\u2013137","journal-title":"Urology"},{"key":"575_CR50","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1089\/end.2014.0866","volume":"29","author":"SL Woldu","year":"2015","unstructured":"Woldu SL, Thoreson GR, Okhunov Z et\u00a0al (2015) Comparison of renal parenchymal volume preservation between partial nephrectomy, cryoablation, and radiofrequency ablation using 3D volume measurements. J\u00a0Endourol 29:948\u2013955","journal-title":"J Endourol"},{"key":"575_CR51","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2215\/CJN.11941116","volume":"12","author":"HD Patel","year":"2017","unstructured":"Patel HD, Pierorazio PM, Johnson MH et al (2017) Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors: a systematic review and meta-analysis. Clin J Am Soc Nephrol 12:1057\u20131069","journal-title":"Clin J Am Soc Nephrol"},{"key":"575_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.juro.2011.03.024","volume":"186","author":"F Altunrende","year":"2011","unstructured":"Altunrende F, Autorino R, Hillyer S et\u00a0al (2011) Image guided percutaneous probe ablation for renal tumors in 65 solitary kidneys: functional and oncological outcomes. J\u00a0Urol 186:35\u201341","journal-title":"J Urol"},{"key":"575_CR53","doi-asserted-by":"publisher","first-page":"E526","DOI":"10.1111\/j.1464-410X.2012.11230.x","volume":"110","author":"GD Schmit","year":"2012","unstructured":"Schmit GD, Thompson RH, Kurup AN et\u00a0al (2012) Percutaneous cryoablation of solitary sporadic renal cell carcinomas. BJU Int 110:E526\u2013E531","journal-title":"BJU Int"},{"key":"575_CR54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00345-016-1913-4","volume":"35","author":"JA Long","year":"2017","unstructured":"Long JA, Bernhard JC, Bigot P et\u00a0al (2017) Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting. World J Urol 35:649\u2013656","journal-title":"World J Urol"},{"key":"575_CR55","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.eururo.2014.07.021","volume":"67","author":"RH Thompson","year":"2015","unstructured":"Thompson RH, Atwell T, Schmit G et\u00a0al (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67:252\u2013259","journal-title":"Eur Urol"},{"key":"575_CR56","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.juro.2009.07.004","volume":"182","author":"SC Campbell","year":"2009","unstructured":"Campbell SC, Novick AC, Belldegrun A et\u00a0al (2009) Guideline for management of the clinical T1 renal mass. J\u00a0Urol 182:1271\u20131279","journal-title":"J Urol"},{"key":"575_CR57","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.juro.2011.11.096","volume":"187","author":"SL Best","year":"2012","unstructured":"Best SL, Park SK, Youssef RF et al (2012) Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters. J\u00a0Urol 187:1183\u20131189","journal-title":"J Urol"},{"key":"575_CR58","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.juro.2008.03.046","volume":"180","author":"CT Nguyen","year":"2008","unstructured":"Nguyen CT, Lane BR, Kaouk JH et\u00a0al (2008) Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy. J\u00a0Urol 180:104\u2013109 (discussion 9)","journal-title":"J Urol"},{"key":"575_CR59","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.juro.2009.07.064","volume":"182","author":"KJ Kowalczyk","year":"2009","unstructured":"Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G (2009) Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J\u00a0Urol 182:2158\u20132163","journal-title":"J Urol"},{"key":"575_CR60","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.juro.2015.09.078","volume":"195","author":"JA Jimenez","year":"2016","unstructured":"Jimenez JA, Zhang Z, Zhao J et\u00a0al (2016) Surgical salvage of thermal ablation failures for renal cell carcinoma. J\u00a0Urol 195:594\u2013600","journal-title":"J Urol"},{"key":"575_CR61","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bju.12743","volume":"115","author":"JA Karam","year":"2015","unstructured":"Karam JA, Wood CG, Compton ZR et\u00a0al (2015) Salvage surgery after energy ablation for renal masses. BJU Int 115:74\u201380","journal-title":"BJU Int"},{"key":"575_CR62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/RLI.0b013e3181c02ed5","volume":"45","author":"HC Bauknecht","year":"2010","unstructured":"Bauknecht HC, Romano VC, Rogalla P et al (2010) Intra- and interobserver variability of linear and volumetric measurements of brain metastases using contrast-enhanced magnetic resonance imaging. Invest Radiol 45:49\u201356","journal-title":"Invest Radiol"},{"key":"575_CR63","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1349-7006.2003.tb01394.x","volume":"94","author":"H Watanabe","year":"2003","unstructured":"Watanabe H, Yamamoto S, Kunitoh H et\u00a0al (2003) Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci 94:1015\u20131020","journal-title":"Cancer Sci"},{"key":"575_CR64","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1148\/radiol.2353040332","volume":"235","author":"S Shankar","year":"2005","unstructured":"Shankar S, van Sonnenberg E, Desai J, Dipiro PJ, Van Den Abbeele A, Demetri GD (2005) Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology 235:892\u2013898","journal-title":"Radiology"},{"key":"575_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1148\/rg.282075068","volume":"28","author":"C Suzuki","year":"2008","unstructured":"Suzuki C, Jacobsson H, Hatschek T et\u00a0al (2008) Radiologic measurements of tumor response to treatment: practical approaches and limitations. Radiographics 28:329\u2013344","journal-title":"Radiographics"},{"key":"575_CR66","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/j.crad.2013.05.094","volume":"68","author":"A Elmi","year":"2013","unstructured":"Elmi A, Hedgire SS, Covarrubias D, Abtahi SM, Hahn PF, Harisinghani M (2013) Apparent diffusion coefficient as a\u00a0non-invasive predictor of treatment response and recurrence in locally advanced rectal cancer. Clin Radiol 68:e524\u201331","journal-title":"Clin Radiol"},{"key":"575_CR67","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00261-011-9807-9","volume":"37","author":"JD Iannuccilli","year":"2012","unstructured":"Iannuccilli JD, Dupuy DE, Mayo-Smith WW (2012) Solid renal masses: effectiveness and safety of image-guided percutaneous radiofrequency ablation. Abdom Imaging 37:647\u2013658","journal-title":"Abdom Imaging"},{"key":"575_CR68","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.euf.2015.04.001","volume":"1","author":"P Capogrosso","year":"2016","unstructured":"Capogrosso P, Capitanio U, La Croce G et al (2016) Follow-up after treatment for renal cell carcinoma: the evidence beyond the guidelines. Eur Urol Focus 1:272\u2013281","journal-title":"Eur Urol Focus"},{"key":"575_CR69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.juro.2013.04.121","volume":"190","author":"SM Donat","year":"2013","unstructured":"Donat SM, Diaz M, Bishoff JT et al (2013) Follow-up for clinically localized renal neoplasms: AUA guideline. J\u00a0Urol 190:407\u2013416","journal-title":"J Urol"},{"key":"575_CR70","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","volume":"67","author":"B Ljungberg","year":"2015","unstructured":"Ljungberg B, Bensalah K, Canfield S et\u00a0al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913\u2013924","journal-title":"Eur Urol"},{"key":"575_CR71","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.eururo.2015.07.003","volume":"69","author":"A Larcher","year":"2016","unstructured":"Larcher A, Fossati N, Tian Z et\u00a0al (2016) Prediction of complications following partial nephrectomy: implications for ablative techniques candidates. Eur Urol 69:676\u2013682","journal-title":"Eur Urol"},{"key":"575_CR72","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.eururo.2013.03.034","volume":"65","author":"M Sun","year":"2014","unstructured":"Sun M, Becker A, Tian Z et al (2014) Management of localized kidney cancer: calculating cancer-specific mortality and competing risks of death for surgery and nonsurgical management. Eur Urol 65:235\u2013241","journal-title":"Eur Urol"},{"key":"575_CR73","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1097\/01.ju.0000119905.72574.de","volume":"171","author":"JJ Hwang","year":"2004","unstructured":"Hwang JJ, Walther MM, Pautler SE et\u00a0al (2004) Radio frequency ablation of small renal tumors:: intermediate results. J\u00a0Urol 171:1814\u20131818","journal-title":"J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-018-0575-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T00:25:48Z","timestamp":1549067148000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-018-0575-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1007\/s00120-018-0575-9","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"assertion":[{"value":"2 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.C.\u00a0Kriegmair, N.\u00a0Wagener, S.J.\u00a0Diehl und N.\u00a0Rathmann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}